PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

89 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
41.
Johnson, S.B.* ; Lynch, K.F.* ; TEDDY Study Group (Roth, R.) & Schatz, D.*: My child is islet autoantibody positive: Impact on parental anxiety. Diabetes Care 40, 1167-1172 (2017)
42.
Kollerits, B.* et al.: Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: A pooled analysis in more than 20,000 individuals. Diabetes Care 40, 1386-1393 (2017)
43.
Krischer, J.P.* et al.: Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: The TEDDY Study. Diabetes Care 40, 1194-1202 (2017)
44.
Frank, S.* et al.: Neuronal food reward activity in patients with type 2 diabetes with improved glycemic control after bariatric surgery. Diabetes Care 39, 1311-1317 (2016)
45.
Jordan, J.* ; El-Armouche, A.* ; Hanefeld, M.* ; Bornstein, S.R. & Birkenfeld, A.L.: CV Protection in the EMPA-REG OUTCOME Trial: A "Thrifty Substrate" Hypothesis. Diabetes Care 2016;39:1108-1114. Diabetes Care 39, E224-E225 (2016)
46.
Vehik, K.* et al.: Reversion of β-cell autoimmunity changes risk of type 1 diabetes: TEDDY study. Diabetes Care 39, 1535-1542 (2016)
47.
Bonifacio, E.: Predicting type 1 diabetes using biomarkers. Diabetes Care 38, 989-996 (2015)
48.
Brandmaier, S. et al.: Response to Comment on Xu et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 2015;38:1858-1867. Diabetes Care 38, e216-e217 (2015)
49.
Herder, C.* et al.: Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: Results from the KORA F4 study. Diabetes Care 38, 91-96 (2015)
50.
Insel, R.A.* et al.: Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964-1974 (2015)
51.
Kemppainen, K.M.* et al.: Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care 38, 329-332 (2015)
52.
Kullmann, S. et al.: Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care 38, 1044-1050 (2015)
53.
Shariful Islam, S.M.* et al.: Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: A prospective, parallel-group, randomized controlled trial. Diabetes Care 38, e112-e113 (2015)
54.
Steck, A.K.* et al.: Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care 38, 808-813 (2015)
55.
Xu, T. et al.: Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 38, 1858-1867 (2015)
56.
Beyerlein, A. et al.: Timing of gluten introduction and islet autoimmunity in young children: Updated results from the BABYDIET study. Diabetes Care 37, e194-e195 (2014)
57.
Krause, S. et al.: GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial. Diabetes Care 37, 1675-1680 (2014)
58.
Laxy, M. et al.: The association between patient-reported self-management behavior, intermediate clinical outcomes, and mortality in patients with type 2 diabetes: Results from the KORA-A study. Diabetes Care 37, 1604-1612 (2014)
59.
Raz, I.* et al.: Treatment of recent-onset type 1 diabetic patients with DiaPep277: Results of a double-blind, placebo-controlled, randomized phase 3 trial. Diabetes Care 37, 1392-1400 (2014)
60.
Smith, L.B.* et al.: Factors associated with maternal-reported actions to prevent type 1 diabetes in the first year of the TEDDY study. Diabetes Care 37, 325-331 (2014)